Daniel H. Ciccarone, MD, MPH, has been providing community-based primary care in San Francisco for 15 years. He is Assistant Professor of Family and Community Medicine and Anthropology, History and Social Medicine at UCSF, where he directs a number of research projects on the prevention and treatment of HIV infection and substance abuse. His publications have appeared in JAMA, NEJM, AJPH, MMWR, CID, Substance Use and Misuse, and the International Journal of Drug Policy. Recently he has received a grant to study the social, behavioral and medical consequences of national and international distribution of heroin, including sources, types and qualities. At the UCSF Medical School he takes pride in revising medical curricula to enhance competencies in working with diverse populations.

• Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, Edlin BR. Risk Factors for Skin and Soft Tissue Abscess among Injection Drug Users: A Case-Control Study. CID 2001; 33:35-40.
• Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider Assessment of Adherence to HIV Antiretroviral Therapy. JAIDS 2001; 26:435-442.
• Edlin BR, Seal KH, Lorvick J, Kral AH, Ciccarone DH, Moore LD, Lo B and the Hepatitis C Injection Drug Use Treatment Policy Group. Is it Justifiable to Withhold Treatment for Hepatitis C from Illicit Drug Users? New Eng J of Med. 2001; 345:211-214.
• Ciccarone D, Bamberger J, Kral A, Hobart CJ, Moon A, Edlin BR, Harris HW, Young DM, Bourgois P, Murphy EL. Soft Tissue Infections Among Injection Drug Users – San Francisco, California, 1996-2000. MMWR 2001; 50:381-384. [Reprinted in JAMA 2001; 285 (21):2707-2709.]
• Ciccarone D. With Both Eyes Open: Notes on a Disciplinary Dialogue between Ethnographic and Epidemiological Research among Injection Drug Users. IJDP 2003; 14:115-118.
• Ciccarone D, Kanouse D, Collins R, Mui A, Chen J, Morton S, Stall R. Sex without Disclosure of Positive HIV Serostatus in a U.S. Probability Sample of Persons Receiving Medical Care for HIV Infection. AJPH 2003; 93:949-954. Digested in: Perspect Sex Reprod Health 2003; 35:235-6.
• Seal K, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, Ciccarone D, Edlin B. Attitudes about Prescribing Take-Home Naloxone to Injection Drug Users for the Management of Heroin Overdose: A Survey of Street-Recruited Injectors in the San Francisco Bay Area. J Urban Health 2003; 80: 291-301.
• Ciccarone D, Bourgois P. Explaining the Geographic Variation of HIV among Injection Drug Users in the United States. Substance Use and Misuse 2003; 38(14): 2049-2063.
• Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Edlin BR, Ciccarone D, Ng V, Chansky K, Chambers HF. Origins of Community Strains of Methicillin Resistant Staphylococcus aureus. CID. In press 2004
• Ciccarone D, Coffin P, Preer G. Integration of HIV Risk Reduction into the Medical Curriculum. Med Ed. In press 2004
• Duru K, Kanouse D, Collins R, Mui A, Chen J, Morton S, Ciccarone D, Stall R. Correlates of sex without serostatus disclosure among a national probability sample of HIV patients. AJPH. Submitted 2004
• Cho KC, Nash SR, Ciccarone D, Rodriguez RA. Renal AA Amyloidosis among Black Tar Heroin Users in San Francisco. Arch Int Med. Submitted 2004
• Seal KH, Thawley B, Gee L, Bamberger J, Kral AH, Ciccarone D, Downing M, Edlin BR. Providing Naloxone and Resuscitation Training to Injection Drug Users to Prevent Fatal Heroin Overdose. J Urban Hlth. Submitted 2004
• Mannheimer SB, Mukherjee R, Hirschhorn L, Dougherty J, Celano SA, Ciccarone D, et al. Measuring Adherence to Antiretroviral Therapy. JAIDS. Submitted 2004
• Kral AH, Lorvick J, Ciccarone D, Wenger L, Gee L, Martinez A, Edlin BR. HIV Prevalence and Risk Behaviors among Men Who Have Sex With Men and Inject Drugs in San Francisco. J Urban Hlth. Submitted 2004.
• Gerbert B, Allerton M, Gilbert P, Danley D, Ciccarone D. How HIV-Care Providers Can Approach Risk-Reduction without ”Blaming the Victim.” AIDS Patient Care STDs. Submitted 2004

• Bourgois P, Ciccarone D. “Confronting the Logics for Needle Sharing among Homeless Heroin Addicts: A Challenge for HIV Prevention Outreach,” University AIDS Research Program Conference, San Francisco, California, April 1999.
• Ciccarone D. “Action Point Evaluation,” Center for Adherence Support Evaluation, New York Academy of Medicine, New York, November 22-23, 1999.
• Seal K, Downing M, Kral AH, Hammond JP, Singleton-Banks S, Kingsley S, Gee L, Ciccarone D, Edlin BR. “Listening to Users: Attitudes about the Feasibility of Providing Naloxone to IDUs to Prevent Death From Heroin Overdose,” Preventing Heroin Overdose: Pragmatic Approaches, Seattle, Washington, January 13-14, 2000.
• Bangsberg DR, Hecht FM, Clague H, Charlebois E, Ciccarone D, Chesney M, Moss AR. “Provider Estimate (PE) and Structured Patient Report (SPR) of Adherence Compared to Unannounced Pill Count (UPC),” National Retrovirus Conference, San Francisco, California, February 7-11, 2000.
• Farmer P, Ciccarone D. “In Conversation with Paul Farmer,” HIV InSite and Center for AIDS Prevention Studies, San Francisco, California, March 21, 2000.
• Edlin BR, Lorvick J, Kral AH, Seal K, Ciccarone D, Lo B. “Withholding Treatment for HCV Infection from Injection Drug Users: An Ethical Analysis,” Tenth International Symposium on Viral Hepatitis and Liver Disease, Atlanta, Georgia, April 2000.
• Rubin S, Giuliano R, Ciccarone D, Jacobs E. “Youth Caucus: Providing Medical Services to At-Risk Youth,” National Syringe Exchange Conference X, Portland, Oregon, April 27-29, 2000.
• Ciccarone D, Stall R, Collins R, Berry S, Chen J, Mui A, Morton S, Kanouse D. “Frequency of High Risk Sex without Disclosure in Serodiscordant Relationships in a U.S. Probability Sample of Persons Receiving HIV Care,” XIII International AIDS Conference, Durban, South Africa, July 9-14, 2000.
• Ciccarone D, Giuliano R. “User-friendly Approaches to Abscess Treatment and Prevention with Young IDUs,” Third National Harm Reduction Conference, Miami, Florida, October 21-25, 2000.
• Ciccarone D, Bourgois P, Murphy E, Kral A, Seal K, Moore J, Edlin B R. “Risk Factors for Abscesses in Injectors of “Black Tar” Heroin: A Cross-methodological Approach,” American Public Health Association Conference, Boston, Massachusetts, November 12-16, 2000.
• Ciccarone D, Bourgois P, Murphy E, Kral A, Seal K, Moore J, Edlin B R. “Soft Tissue Infections among Users of Black Tar Heroin: A Cross-Methodological Examination,” Community Epidemiology Working Group Meeting, National Institutes of Drug Abuse, San Francisco, California, December 12-15, 2000.
• Ciccarone D, Bourgois P, Murphy E, Chambers H, Edlin B. “Biological and Behavioral Predictors of Soft Tissue Infections In Injection Drug Users,” Family Practice Grand Rounds, SFGH, January 25, 2001.
• Young D, Harris H, Ciccarone D, Charlebois E. “Soft Tissue Infections and Injection Drug Use,” Surgery Grand Rounds, UCSF, May 9, 2001.
• Ciccarone D, Bourgois P, Murphy E, Kral A, Seal K, Edlin B R. “Reducing the Risk of Skin and Soft Tissue Infections,” Medical Consequences of Illicit Drug Use: Prevention and Clinical Management, Community Dissemination Conference, The San Francisco Treatment Research Center, San Francisco, California, July 20, 2001.
• Ciccarone D. “ Demystifying the Notion of the ‘Difficult-to-Treat Patient’,” Fifth International HCV Conference, San Francisco, California, August 2-5, 2001.
• Cassidy T, Finkelstein R, Mantell J, McCoy K, Ciccarone D, et al. “Taking HAART – Motivations and Tribulations: Perspectives of Enrollees in Adherence Support Programs, “129th Annual Meeting of the American Public Health Association, Atlanta, Georgia, October 22-25, 2001.
• Mantell J, Finkelstein R, Cassidy T, Aranda-Naranjo B, Ciccarone D, et al. “Adherence Support Interventions for HAART: Critical Issues,” AIDS Impact, Brighton, United Kingdom, July 2001.
• Ciccarone D. “Reduction in HIV-related Hospital Utilization among Action Point Clients,” Center for Adherence Support Evaluation Meeting, Washington, D.C., April 25-6, 2002.
• Ciccarone D and Cho K. “Amyloidosis and Abscess among Heroin Users at San Francisco General Hospital, “ Medicine Grand Rounds, SFGH, June 18, 2002.
• Mannheimer S, Mantell J, Finkelstein R, Aranda-Naranjo B, Ciccarone D, et al. “The Challenges of Assessing Adherence in Community-based Research,” XIV International AIDS Conference, Barcelona, Spain, July 6-13, 2002.
• Capizzi JD, Merzell C, Wilson TE, Mundy LM, Ciccarone D, et al. “ A Taxonomy of HIV Medication Adherence Support Models: Experience from the SPNS Cross-site Evaluation,” 130th Annual Meeting of the American Public Health Association, Philadelphia, PA, November 9-13, 2002.
• Finkelstein R, Mantell J, Cassidy T, Ciccarone D, et al. “Impact of September 11th Events and Their Aftermath among People with HIV/AIDS on Antiretroviral Therapy,” 130th Annual Meeting of the American Public Health Association, Philadelphia, PA, November 9-13, 2002.
• Mantell J, Cassidy T, Finkelstein R, Ciccarone D, et al. “Disclosure of HIV Status and Antiretroviral Therapy: Barriers to Medication Initiation and Adherence?” National Minority AIDS Conference, 2002. (Postponed due to 9/11)
• Seal KH, Edlin BR, Thawley R, Hammond JP, Downing M, Bamberger J, Ciccarone D. “Providing Naloxone to IDUs Can Save Lives,” Fourth National Harm Reduction Conference, Seattle, WA, December 1-4, 2002.
• Wenger LD, Ciccarone DH, Riess TH, Edlin BR. “Facilitators and Barriers of HIV Medication Adherence: Perspectives of Clients and Providers,” Elements of Success: An International Conference on Adherence to Antiretroviral Therapy, Dallas, TX, December 5-8, 2002.
• Ciccarone D. Soft Tissue Infections among Injection Drug Users: Community Strategies for Treatment and Prevention,” Demand Treatment! Partners Institute, National Meeting, San Francisco, CA, April 2 – 5, 2003.
• Mannheimer S, Mantell J, Mukherjee R, Ciccarone D, et al. “Successful Interventions for Antiretroviral Adherence,” 41st Annual Meeting of the Infectious Diseases Society of America (IDSA), San Diego, CA, October 9 - 12, 2003.
• Ciccarone, D. “Culture and Infection: Understanding Risk-taking Among Heroin Users in San Francisco,” California Society of Addiction Medicine Annual Meeting, San Francisco, CA, October 8-11, 2003.
• Finkelstein R, Mantell J, Eldred L, Mukherjee R, Ciccarone D, et al. Effectiveness of Different Adherence Support Program Models in Helping Clients Adhere to HAART, 131st Annual Meeting of the American Public Health Association, San Francisco, CA, November 15-19, 2003.
• Seal KH, Thawley R, Hammond JP, Downing M, Bamberger J, Ciccarone D, Kral, AH, Edlin BR. “Providing Naloxone to Heroin Injectors Can Save Lives,” 131st Annual Meeting of the American Public Health Association, San Francisco, CA, November 15-19, 2003.
• Satterfield J, Ciccarone D, Muller J. Group on Education Affairs / Group on Student Affairs Mini-Workshop: Educational Strategies to Address Health Disparities, 114th Association of American Medical Colleges Annual Meeting, Washington, DC, November 7 – 12, 2003.
• Ciccarone D, Bourgois P. “Heroin in Black and White: Explaining the Unequal Diffusion of HIV among Injection Drug Users in the United States,” Annual Meeting of the American Anthropological Association, Chicago, IL, November 2003. (Session chair)
• Kral AH, Seal KH, Thawley R, Hammond JP, Gee L, Bamberger J, Ciccarone D, Edlin BR. “Providing naloxone and training to IDUs can save lives.” The Central Point Conference. California Department of Health Services, AIDS Office. Sacramento, CA, February 2004.
• Ciccarone, D. “Explaining the Geographical Variation of HIV among Injection Drug Users in the United States,” Practice Improvement Collaborative, Community Behavioral Health Services, San Francisco Department of Pubic Health, San Francisco, CA, March 1, 2004.
• Kral AH, Lorvick L, Ciccarone D, Wenger L, Gee L, Martinez A, Edlin B. “HIV Prevalence and Risk Behaviors Among Men Who Have Sex With Men and Inject Drugs,” New dynamics of HIV risk among drug-using men who have sex with men: Working meeting. National Institutes of Drug Abuse, National Institutes of Health, Bethesda, MD, March 2, 2004.
• Ciccarone D, Coffin P, Preer G. “The Integration of HIV Risk Reduction Education into the Inflammation, Infection and Immunity Block of the Undergraduate Medical Curriculum,” Working Group on Educational Affairs / Working Group on Student Affairs Regional AAMC Conference: “The Reflective Practitioner,” Asilomar Conference Center, Pacific Grove, CA, April 25-28, 2004. Also presented at UCSF Medical Education Day, SF, CA, April 19th, 2004.
• Kral AH, Lorvick J, Ciccarone D, Wenger L, Gee L, Martinez A, Edlin BR. “HIV Prevalence and Risk Behaviors among Men Who Have Sex With Men and Inject Drugs,” International AIDS Conference, Bangkok, Thailand, July 2004.
• Ciccarone D, McMahan B, Bourgois P. “Black Tar Heroin Use Explains Lower HIV Prevalence among Injection Drug Users in the Western United States,” XV International AIDS Conference, Bangkok, Thailand, July 2004.
• Bourgois P, Ciccarone D. “Explaining the Geographical Variation of HIV among Injection Drug Users in the United States,” Invited Speaker, Workshop on HIV and HCV Research Dissemination, Consortium of National Centre in HIV Social Research, The Social Policy Research Centre, University of New South Wales, and Hepatitis C Council of NSW, Sydney, Australia, September, 2004.
• Gilbert P, Gerbert B, Ciccarone D, Danley D, Herzig K. “Positive Choice: A Multimedia Computer Program to Screen for and Intervene on Risky Behaviors of HIV-Positive Patients,” 132nd Annual Meeting of the American Public Health Association, Washington, DC, November 6-10, 2004.
• Maxwell S, Ciccarone D, Rich J. Panel presentation in: “Physician Contributions to the Field and Practice of Harm Reduction,” Fifth Annual Harm Reduction Conference, New Orleans, LA, November 11-14, 2004.
• Ciccarone D, Giuliano R. Panel presentation in: “Beyond Naloxone: Innovations in Treatment of Heroin Overdose,” Fifth Annual Harm Reduction Conference, New Orleans, LA, November 11-14, 2004.
• Ciccarone D. “Heroin in Black and White: Consequences of Use of Different Types of Heroin,” Fifth Annual Harm Reduction Conference, New Orleans, LA, November 11-14, 2004. Abstract submitted
• Ciccarone D. “Paradoxics in the War on Drugs,” presented as part of a panel: “Rethinking the War on Drugs: Insights from Anthropology for Reformulating Public Policy,” Annual Meeting of the American Anthropological Association, San Francisco, CA, November 17-21, 2004.
• Muller JH, Hill-Sakurai L, Ciccarone D, Satterfield JM. “Developing a Curricular Theme in Sociocultural and Behavioral Sciences: The Experience of One Medical School,” 31st Annual Predoctoral Education Conference, Society for Teachers of Family Medicine, Albuquerque, NM, January 27-30, 2005.